Bajorin DF - Search Results

1

Novel blood biomarkers of human urinary bladder cancer.

Osman I, Bajorin DF, Sun TT, Zhong H, Douglas D, Scattergood J, Zheng R, Han M, Marshall KW, Liew CC. Osman I, et al. Among authors: bajorin df. Clin Cancer Res. 2006 Jun 1;12(11 Pt 1):3374-80. doi: 10.1158/1078-0432.CCR-05-2081. Clin Cancer Res. 2006. PMID: 16740760

2

Detection of circulating cancer cells expressing uroplakins and epidermal growth factor receptor in bladder cancer patients.

Osman I, Kang M, Lee A, Deng FM, Polsky D, Mikhail M, Chang C, David DA, Mitra N, Wu XR, Sun TT, Bajorin DF. Osman I, et al. Among authors: bajorin df. Int J Cancer. 2004 Oct 10;111(6):934-9. doi: 10.1002/ijc.20366. Int J Cancer. 2004. PMID: 15300806

3

Phase II trial of pemetrexed as second-line therapy in patients with metastatic urothelial carcinoma.

Galsky MD, Mironov S, Iasonos A, Scattergood J, Boyle MG, Bajorin DF. Galsky MD, et al. Among authors: bajorin df. Invest New Drugs. 2007 Jun;25(3):265-70. doi: 10.1007/s10637-006-9020-9. Epub 2006 Dec 5. Invest New Drugs. 2007. PMID: 17146733 Clinical Trial.

4

Phase II trial of dose-dense doxorubicin plus gemcitabine followed by paclitaxel plus carboplatin in patients with advanced urothelial carcinoma and impaired renal function.

Galsky MD, Iasonos A, Mironov S, Scattergood J, Boyle MG, Bajorin DF. Galsky MD, et al. Among authors: bajorin df. Cancer. 2007 Feb 1;109(3):549-55. doi: 10.1002/cncr.22454. Cancer. 2007. PMID: 17200962 Free article. Clinical Trial.

5

Prospective trial of ifosfamide, paclitaxel, and cisplatin in patients with advanced non-transitional cell carcinoma of the urothelial tract.

Galsky MD, Iasonos A, Mironov S, Scattergood J, Donat SM, Bochner BH, Herr HW, Russo P, Boyle MG, Bajorin DF. Galsky MD, et al. Among authors: bajorin df. Urology. 2007 Feb;69(2):255-9. doi: 10.1016/j.urology.2006.10.029. Urology. 2007. PMID: 17320659 Clinical Trial.

6

The histone deacetylase inhibitor belinostat (PXD101) suppresses bladder cancer cell growth in vitro and in vivo.

Buckley MT, Yoon J, Yee H, Chiriboga L, Liebes L, Ara G, Qian X, Bajorin DF, Sun TT, Wu XR, Osman I. Buckley MT, et al. Among authors: bajorin df. J Transl Med. 2007 Oct 12;5:49. doi: 10.1186/1479-5876-5-49. J Transl Med. 2007. PMID: 17935615 Free PMC article.

7

Shedding of distinct cryptic collagen epitope (HU177) in sera of melanoma patients.

Ng B, Zakrzewski J, Warycha M, Christos PJ, Bajorin DF, Shapiro RL, Berman RS, Pavlick AC, Polsky D, Mazumdar M, Montgomery A, Liebes L, Brooks PC, Osman I. Ng B, et al. Among authors: bajorin df. Clin Cancer Res. 2008 Oct 1;14(19):6253-8. doi: 10.1158/1078-0432.CCR-07-4992. Clin Cancer Res. 2008. PMID: 18829505 Free PMC article.

8

Small-Cell Carcinomas of the Bladder and Lung Are Characterized by a Convergent but Distinct Pathogenesis.

Chang MT, Penson A, Desai NB, Socci ND, Shen R, Seshan VE, Kundra R, Abeshouse A, Viale A, Cha EK, Hao X, Reuter VE, Rudin CM, Bochner BH, Rosenberg JE, Bajorin DF, Schultz N, Berger MF, Iyer G, Solit DB, Al-Ahmadie HA, Taylor BS. Chang MT, et al. Among authors: bajorin df. Clin Cancer Res. 2018 Apr 15;24(8):1965-1973. doi: 10.1158/1078-0432.CCR-17-2655. Epub 2017 Nov 27. Clin Cancer Res. 2018. PMID: 29180607 Free PMC article.

9

Putative Biomarkers of Clinical Benefit With Pembrolizumab in Advanced Urothelial Cancer: Results from the KEYNOTE-045 and KEYNOTE-052 Landmark Trials.

Bellmunt J, de Wit R, Fradet Y, Climent MA, Petrylak DP, Lee JL, Fong L, Necchi A, Sternberg CN, O'Donnell PH, Powles T, Plimack ER, Bajorin DF, Balar AV, Castellano D, Choueiri TK, Culine S, Gerritsen W, Gurney H, Quinn DI, Vuky J, Vogelzang NJ, Cristescu R, Lunceford J, Saadatpour A, Loboda A, Ma J, Rajasagi M, Godwin JL, Homet Moreno B, Grivas P. Bellmunt J, et al. Among authors: bajorin df. Clin Cancer Res. 2022 May 13;28(10):2050-2060. doi: 10.1158/1078-0432.CCR-21-3089. Clin Cancer Res. 2022. PMID: 35247908 Clinical Trial.

10

Phase II trial of suramin in patients with advanced renal cell carcinoma: treatment results, pharmacokinetics, and tumor growth factor expression.

Motzer RJ, Nanus DM, O'Moore P, Scher HI, Bajorin DF, Reuter V, Tong WP, Iversen J, Louison C, Albino AP, et al. Motzer RJ, et al. Among authors: bajorin df. Cancer Res. 1992 Oct 15;52(20):5775-9. Cancer Res. 1992. PMID: 1394202 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

289 results

Search Page

Filters